« More low-fat recipes: double chocolate chip cookies  | Main  | asking for directions: the alli roadmap »

what's the difference between the alli blog and the alli message board?

Katrina and I thought it would be a good time to clarify this as some readers are leaving comments on the blog that are more appropriate for the alli message board. Namely, very specific questions about the use of alli: product availability, directions for use, drug interactions, etc. These comments won't be posted on alliConnect. (See our Comments policy.)

Here's why: both this blog and the alli message board are places for an exchange of information and for discussion. However, the message board is specifically designed to answer questions about individual experiences of using alli and the alli plan (like those mentioned above). It's staffed by a group of weight loss experts, including dieticians, pharmacists and fitness professionals, who are compensated by GSK but whose opinions are their own. If you choose, you can also get answers by using the contact us function on myalli.com.

The blog, in contrast, is a place to talk about broader issues surrounding weight loss, as well as to draw open the curtain on the educational marketing campaign behind alli. It's also a way to speak directly to the branding team, including GSK Consumer Healthcare VP of weight loss Steve Burton.

Stay tuned and thanks for your patience.

Useful Links

alli message board

Frequently Asked Questions about alli (on myalli.com)

Comment and Response policy on the message board

Comments policy on the alli blog

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.

 

   

 

Post

about this blog

  • alliConnect is GlaxoSmithKline's official corporate blog for alli, the only FDA-approved, OTC weight loss product. It's a place for you to have a conversation with us about weight loss issues. Because we work for a drug company we do have to abide by a few rules. Legal stuff...

Subscribe

  • RSS feed

    Enter your email address below to receive an email whenever a new entry is published.

comments policy

  • We want to hear from you! We review all comments in advance. Please stay on topic, be respectful of others' views and avoid profanity. More about our comments policy

Search this blog

Go

About the authors

contact us

about gsk